Try our mobile app

Trading Statement in respect of Aspen’s results for the six months ended 31 December 2021

Published: 2022-02-01 06:00:00 ET
<<<  go to JSE:APN company page
Aspen Pharmacare Holdings Limited (JSE:APN) News - Trading Statement in respect of Aspen’s results for the six months ended 31 December 2021

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)


Trading Statement In Respect Of Aspen’s Results For The Six Months Ended 31
December 2021

The Business Update announcement published on 18 January 2022 provided guidance on
the operational performance results for the six months ended 31 December 2021. In terms of
paragraph 3.4(b) of the JSE Limited Listings Requirements, this trading statement is provided
to the shareholders of Aspen as guidance on the key earnings measures relating to the results
of the Group for the six months ended 31 December 2021, expected to be published on SENS
after market close on 9 March 2022.

The reported earnings measures for the six months ended 31 December 2021 are expected
to vary from those reported in the prior six months ended 31 December 2020 within the ranges
as set out in the table below.

       Earnings measures                  Range (%)            Range (Cents per share)             Cents per share
                                                                   - 31 December 2021           - 31 December 2020
 NHEPS* – Continuing                      18% to 22%                   798.0 to 825.0                        676.2
 Operations
 Headline earnings per share –            34% to 38%                   758.7 to 781.3                        566.2
 Total Operations**
 Earnings per share – Total               29% to 33%                   720.3 to 742.6                        558.4
 Operations **

* Normalised headline earnings per share (“NHEPS”) comprises headline earnings per share adjusted for specific
non-trading items (“normalisation adjustments”) in accordance with Aspen’s accounting policies.

** Includes continuing and discontinued operations

NHEPS is the primary measure used by management to assess Aspen’s underlying financial
performance. Growth in NHEPS is lower than growth in headline earnings per share and
earnings per share primarily as a result of reduced normalisation adjustments in the current
year relating mainly to restructuring costs and transaction related costs which do not impact
the growth in headline earnings per share or earnings per share.

The stronger ZAR, relative to the comparative period, diluted the growth in all earnings
measures and, accordingly, the growth in constant exchange (“CER”) rate earnings measures
is higher than the reported earnings growth as set out above.

The financial results on which this trading statement is based have not been reviewed or
reported on by Aspen’s external auditors.

Durban
01 February 2022

Sponsor
Investec Bank Limited

Date: 01-02-2022 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.